Am J Transplant, Volume 19, Suppl 3 Archives - Page 181 of 214 - ATC Abstracts

2019 American Transplant Congress
Prevalence of Donor Specific Antibody in Heart Transplant Recipients with Antibody-Mediated Rejection as Compared to Abnormal Intragraft mRNA Transcripts by Molecular Microscope System
K. Shah, R. J. Levine, S. Dimbil, S. Sana, P. F. Halloran, J. Patel, D. H. Chang, E. Kransdorf, M. Kittleson, J. A. Kobashigawa
Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
*Purpose: Antibody-mediated rejection (AMR) is defined by pathologic evaluation of endomyocardial biopsy (EMB) for both histologic and immunopathologic components. Detectable donor specific antibodies (DSAs) in…
2019 American Transplant Congress
Is Muscular Dystrophy A Contraindication To Heart Transplantation?
M. Kittleson, J. Patel, D. H. Chang, S. Dimbil, R. Levine, L. Czer, J. A. Kobashigawa
Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
*Purpose: Patients with muscular dystrophy may have an associated cardiomyopathy, resulting in advanced heart failure requiring transplantation. However, the skeletal muscle dysfunction can result in…
2019 American Transplant Congress
HOPE Act Deceased Donors Referrals: Barriers to Donation
O. Kusemiju, C. Durand, B. Doby, M. Bowring, B. Barnaba, W. Werbel, D. Brown, A. Tobian, S. Seaman, D. Ostrander, D. Segev
Johns Hopkins University, Baltimore, MD
*Purpose: HIV+ deceased donors (D+) represent a unique resource for HIV+ recipients but HIV D+ may have medical contraindications to donation or lower authorization rates.…
2019 American Transplant Congress
Transplant Outcomes of DCD Kidneys Recovered with vs. without Pre-Recovery Heparin Administration
J. Narvaez, L. Kayler
Division of Transplantation, University at Buffalo, Buffalo, NY
*Purpose: DCD kidney transplants are associated with higher rates of delayed graft function (DGF) and primary non-function (PNF) likely due to ischemic events during recovery.…
2019 American Transplant Congress
Impact of Cold Ischemia Time on DCD Kidney Transplant Outcomes
J. Narvaez, L. Kayler
Transplant Surgery Division, Dept of Surgery, University at Buffalo, Buffalo, NY
*Purpose: Kidney transplantation (KTX) from Donation after Circulatory Death (DCD) donors is associated with high rates of delayed graft function (DGF) and potential worse graft…
2019 American Transplant Congress
5-Year Post-Transplant Outcomes with Bortezomib-Based Desensitization in Renal Transplant Recipients
K. Zheng¹, S. Tremblay¹, A. R. Shields², M. A. Cardi², J. Kremer², R. R. Alloway¹, E. S. Woodle¹
¹U of Cincinnati, Cincinnati, OH, ²Christ Hospital, Cincinnati, OH
*Purpose: Renal transplant (RT) after desensitization (DS) has been associated with increased rejection rates. Proteasome inhibitor(PI)-based DS yields significant reductions in HLA Ab among sensitized…
2019 American Transplant Congress
Safety and Efficacy of Alemtuzumab Compared to Rabbit Anti-Thymocyte Globulin as Induction for Secondary Transplant after a Primary Transplant with Alemtuzumab Induction
J. L. Fose¹, M. R. Jorgenson¹, G. E. Leverson², R. R. Redfield²
¹Pharmacy, UW Health, Madison, WI, ²University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI
*Purpose: Alemtuzumab and rabbit anti-thymocyte globulin (rATG) are commonly used lymphocyte depleting induction agents. Traditional thinking suggests that re-transplantation is associated with higher rejection risk,…
2019 American Transplant Congress
Comparing the Rate of Opportunistic Infection after Renal Transplant between Alemtuzumab and Basiliximab for Induction Immunosuppression
J. A. Seaman¹, S. G. Westphal², F. Qiu³, D. Bremers⁴, D. Florescu⁵
¹College of Medicine, University of Nebraska Medical Center, Omaha, NE, ²Internal Medicine Division of Nephrology, University of Nebraska Medical Center, Omaha, NE, ³Biostatistics, University of Nebraska Medical Center, Omaha, NE, ⁴Donate Life, Nebraska Medicine, Omaha, NE, ⁵Internal Medicine Division of Infectious Disease, University of Nebraska Medical Center, Omaha, NE
*Purpose: The aim of our study was to compare the outcomes one-year after renal transplant with a focus on opportunistic infections in patients who received…
2019 American Transplant Congress
Epidemiology of Parvovirus B19 and Anemia among Kidney Transplant Recipients
N. Khoury¹, C. Thongprayoon², N. Leeaphorn³, J. Bruminhent⁴, W. Cheungpasitporn⁵
¹Henry Ford Transplant Institute, Detroit, MI, ²Mayo Clinic, Rochester, MN, ³University of Missouri, Kansas City, MO, ⁴Mahidol University, Bangkok, Thailand, ⁵University of Mississippi, Jackson, MS
*Purpose: Persistent anemia has been described in kidney transplant (KTx) recipients with Parvovirus B19 virus infection. However, epidemiology of Parvovirus B19 and Parvovirus B19-related anemia…
2019 American Transplant Congress
The Significance and Impact of Screening Preservation Fluid Cultures in Renal Transplant Recipients
A. Reticker, A. Lichvar, A. Gross, E. Benedetti, S. Patel
University of Illinois Hospital and Health Sciences System, Chicago, IL
*Purpose: Preservation fluid (PF) is necessary to maintain organ viability but serves as a vector for infection. The utility of routine PF screening and impact…